Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05781334 · ClinicalTrials.gov registry record · NA
Optimizing In-hospital Use of Evidence-based Therapies for Patients With Cardio-Renal-Metabolic Disease
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT05781334 is a NA study that has completed, run by Duke University. The registered enrollment target is 202 participants.
The verdict
NCT05781334, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
This study will be a prospective randomized implementation trial for patients hospitalized with heart failure, chronic kidney disease, and/or type 2 diabetes mellitus within Duke University Medical Center. The primary hypothesis is that a virtual quality improvement-based consult intervention will improve the rate of in-hospital evidence-based cardio-renal-metabolic medication use, particularly SGLT2 inhibitor therapy. Approximately 200 patients meeting eligibility criteria will be included in the study. Patients will be assigned into study groups, as defined by randomization of their treating clinician team to receiving the virtual consult versus not.
Interventions
- OTHER Virtual Consult Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05781334
The ClinicalTrials.gov registry entry for NCT05781334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Consult Intervention is the first listed.
NCT05781334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05781334 about?
NCT05781334 is a clinical study titled "Optimizing In-hospital Use of Evidence-based Therapies for Patients With Cardio-Renal-Metabolic Disease". This study will be a prospective randomized implementation trial for patients hospitalized with heart failure, chronic kidney disease, and/or type 2 diabetes mellitus within Duke University Medical Center. The primary hypothesis is that a virtual quality improvement-based consult intervention will i...
What is the current status of trial NCT05781334?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2023-06-09. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT05781334?
The interventions under investigation include: Virtual Consult Intervention (OTHER).
Who is sponsoring clinical trial NCT05781334?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.